Are you sure you want to hide the widget forever? If you need it back, please clear your cookies.
Content
Colors
Navigation
Selected Language
English (United States)
All Languages
Accessibility Statement
Our Commitment to Accessibility
We are committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards to help users with various disabilities access our website effectively.
Compliance Status
Our website strives to conform to the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA standards. We also aim to be compliant with the Americans with Disabilities Act (ADA) and the European Accessibility Act requirements. These guidelines and regulations explain how to make web content more accessible to people with a wide range of disabilities. We acknowledge that some aspects of our website may not yet achieve full compliance, and we are actively working to address these areas.
Accessibility Features Available
Our website implements the Accessibly App, which provides a variety of tools to enhance website accessibility:
Visual Adjustments
Bigger Text: Increase text size up to 3x for better readability (WCAG 2.1/1.4.4)
Bigger Cursor: Enhanced cursor visibility for easier navigation
Color Adjustments: Invert colors, adjust contrast, brightness, and saturation
Grayscale Mode: Convert website to grayscale for users with visual impairments
Hide Images: Reduce visual distractions for easier reading
Reading and Navigation Aids
Reading Line: Adds a guide line to help follow text
Reading Mask: Places a mask over text to isolate lines and enhance focus
Readable Fonts: Converts to highly legible fonts for better comprehension
Highlight Links: Makes links more prominent for easier navigation
Dyslexic Fonts: Special typography for users with dyslexia
Page Structure: Simplified layout options for easier navigation
Assistive Technologies
Keyboard Navigation: Full website control using keyboard (Tab, Shift+Tab, Enter)
Alt Text for Images: AI-generated image descriptions where manual ones aren't provided
Read Page Aloud: Text-to-speech functionality
Stop Animations: Pause motion content for users with vestibular disorders
Limitations and Feedback
Despite our best efforts to ensure accessibility, there may be some limitations. Content provided by third parties, user-generated content, or certain legacy pages may not be fully accessible. We are continuously working to improve our website's accessibility.
We welcome your feedback on the accessibility of our website. If you encounter any barriers or have suggestions for improvement, please contact us. We are committed to addressing these issues promptly.
Technical Information
The accessibility features on this website are provided through the Accessibly App, which utilizes several technologies including HTML, CSS, JavaScript, and various frameworks to enhance accessibility. Our implementation strives to be compatible with major screen readers and assistive technologies.
Legal Disclaimer
While we strive to adhere to WCAG 2.1 Level AA standards and provide accessible content, we cannot guarantee that our website will be accessible to all users under all circumstances. This website is provided 'as is' without any representations or warranties, express or implied.
In no event shall we be liable for any damages arising from or related to:
Inability to access or use the website
Any alleged non-compliance with accessibility laws or regulations
Any disruption or errors in the functionality of accessibility features
By using this website, you agree to hold us harmless from any claims related to website accessibility issues. We are committed to addressing accessibility barriers in good faith but cannot guarantee immediate resolution in all cases.
Contact Us
If you have any questions about our accessibility efforts or encounter any barriers while using our website, please contact us.
Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
August 24, 2023 08:00 am ETEstimated Read Time: 5 Minutes
A group of legislators have reintroduced a bipartisan bill aimed at ensuring cannabidiol (CBD) is adequately regulated in the United States. The Hemp Access and Consumer Safety Act is designed to push the Food and Drug Administration (FDA) to take decisive steps to control the use of hemp-derived CBD in foods, beverages, and dietary supplements.
The U.S. Congress had previously passed the Farm Bill that legalized the cultivation and sale of hemp and hemp products in 2018. However, five years later, the FDA still hasn’t developed a framework for its regulation.
Hemp and the 2018 Farm Bill
The 2018 Bill removed hemp from the list of controlled commodities, allowing it to be legally produced and sold in the State. It also categorized the substance as covered under crop insurance, and the Federal Crop Insurance Corporation board was given the responsibility to develop hemp policies.
According to the legislation, hemp refers to the cannabis plant and ” any part of the plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis.” Also, the bill outlines that plans should be developed to regulate the substance. The existing uncertainty on the marketing of hemp products has affected the production and consumption of CBD.
The Hemp Access and Consumer Safety Act
This recent legislation is an update in the federal laws and ensures the FDA regulates hemp-derived CBD products under the federal Food, Drug, and Cosmetic Act (FD&C Act). It was introduced on July 20, by Rep. Earl Blumenauer (D), Sen. Ron Wyden (D) and Jeff Merkley (D) from Oregon, and Sen. Rand Paul (R) from Kentucky. These bipartisan legislators described the bill in a joint statement as “an action that is essential to protecting consumer safety and treating hemp producers fairly.”
Wyden explained that “Despite being legally grown in the United States for nearly five years, hemp and hemp-derived CBD are still in a regulatory gray zone that puts consumers at risk and holds producers back.” He further stated that “The FDA says it needs Congress to act. We’ve got the bill to ensure equal and safe access to hemp-derived CBD.”
Paul, who was formerly an ophthalmologist for over 15 years, also said that “Hemp-derived CBD products and businesses have earned their recognition in the marketplace, but the FDA, unfortunately, hasn’t treated them like any other food additive or dietary supplement. The Hemp Access and Consumer Safety Act directs the FDA to regulate hemp products properly and provides a huge relief to hemp farmers, processors, and merchants.”
See If You Qualify For Medical Marijuana -Select Your State!
The proposed bill is supported by key hemp and CBD industries like the Wine and Spirits Wholesalers Association (WSWA), the Hemp Roundtable, Hemp Industries Association (HIA), National Hemp Growers Association, Realm of Caring, U.S. Hemp Authority (USHA), National Industrial Hemp Council and the Veterinary Cannabis Society.
Jonathan Miller, the general counsel of the Hemp Roundtable, expressed his optimism as regards the act. He said it would provide the “much-needed pathway for FDA to establish a clear and consistent framework for the production, marketing, and sale of hemp-derived CBD to ensure consumer safety while fostering a thriving, regulated market.”
The Regulatory Role of the FDA
The FDA is ladened with the responsibility to protect public health by ensuring effective pathways to manage the manufacture and commerce of certain commodities. The legalization of cannabis and cannabis-derived products like CBD, alongside the increasing public interest in the substance, necessitates the need to monitor its consumption. Cannabis and its derived products should be subject to the same guidelines and requirements put in place for other FDA-controlled goods.
What Is Expected
It is expected that the FDA creates pathways to make sure hemp-derived products are lawfully introduced as food, beverages, or dietary supplements. In light of this expectation, bipartisan leaders of high-ranking House and Senate Committees are out to obtain vital information from experts on the matter using a Request for Information (RFI). The effort is led by the chairs and top members of the House Energy & Commerce Committee, and the Senate Health, Education, Labor, and Pensions (HELP) Committee to discuss these FDA-CBD-related issues.
The Request for Information
The RFI posed some questions to the FDA on July 27, 2023. Seeking clarity on the current market dynamics, it asks, “What does the current market for CBD products look like? Please describe the types and forms of products available, manufacturing practices within the industry, market supply chain, how products are marketed and sold, the types of cannabinoids used in products, the marketed effects of CBD products, and the range of CBD doses currently found in the market.”
As regards possible pathways for regulations, it asks, “Please comment on the concerns FDA has raised with regard to regulating most CBD products through existing pathways (i.e., conventional foods, dietary supplements, and cosmetics), and FDA’s view that there is a need for a new regulatory pathway for CBD products. If existing regulatory pathways are sufficient for regulating CBD products, please explain how these existing pathways can be used to address the concerns raised by FDA, as appropriate.”
It also asks questions like “What is currently known about the safety and risk-benefit profile of CBD and other hemp-derived cannabinoids? What safety and toxicity data are available to support this knowledge? Please include in your answer any relevant information about safety with regard to specific populations, such as children and pregnant individuals.” And, “How should a new framework for CBD products balance consumer safety with consumer access?”
The RFI included a total of 29 questions and was signed by Bernie Sanders, Bill Cassidy, Cathy McMorris Rodgers, and Frank Pallone. Responses are to be submitted by August 18, 2023.
Mary Ekundayo is a passionate cannabis writer and entrepreneur with a love for all things literary. When she's not creating content, you can find Mary lost in the pages of a captivating book or meditating to set the tone for her day.
Currently, 24 states sell cannabis recreationally. If you are in one of these states, it’s understandable that you might feel tempted to forget about the medical card process. Even if you qualify as a patient, it’s an application process that does take some information and patience. While recreational cannabis is available in many states, there…
What gives cannabis its powerful effects, rich aroma, and frosty appearance? The answer lies in crystal-like structures called trichomes that cover the surface of cannabis flowers. This is where the cannabis cultivation magic happens because they produce and store the majority of compounds responsible for the plant’s potency, flavor, and therapeutic benefits. Trichomes are the…
If pain is an aspect of your cannabis journey, you might be interested in a Green Dragon tincture. This homemade creation will not turn you into a magic dragon, but it could make you feel on top of the world if you are dealing with chronic pain. Pain can slow us down. When the body…
Cannabis is known for its significant effect on the human brain—which is what makes it so beneficial for helping people with mental health conditions. However, the portion of the brain responsible for speech can also be affected. After consuming cannabis, some people may experience acute, subtle speech deviations or difficulties, primarily in maintaining the logical…
There is a lot to learn when it comes to the world of cannabis concentrates. In particular, proper banger health is essential for any dab rig. The devices used to smoke concentrates are not called a bowl, but one of the most popular forms of consumption seems to be using a dab rig. Dab rigs…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.